Pharmacists in Colorado Springs, Colorado
443 Pharmacists found in Colorado Springs
Kate Deen Taucher, PHARMD
Pharmacist - Oncology
525 N Foote Ave, Suite 202, Colorado Springs, CO 80909
719-365-6576
Katharine Elizabeth Forney, PHARM.D.
Pharmacist
8705 Lexington Dr, Colorado Springs, CO 80920
719-282-7797
Dr. Katherine Boudreaux, PHARM. D.
Pharmacist - Pharmacotherapy
225 S Union Blvd, Colorado Springs, CO 80910
719-344-6200 719-344-7829
Kathleen Daniels
Pharmacist
815 Cheyenne Meadows Rd, Colorado Springs, CO 80906
719-527-1640 719-538-6056
Dr. Kathleen S Kenny, RPH, PHARMD
Pharmacist
3250 Centennial Blvd, Colorado Springs, CO 80907
719-866-6646
Dr. Kathleen Marie Grall, PHARM. D
Pharmacist
5050 N Nevada Ave, Colorado Springs, CO 80918
719-264-5019 719-264-5016
Kathleen Anne Twomey, B.S.
Pharmacist
5240 N Academy Blvd, T-154, Colorado Springs, CO 80918
719-262-6638
Kathryn Harriet Sullivan, RPH
Pharmacist
2890 N Powers Blvd, Colorado Springs, CO 80922
719-573-4759 719-573-1066
Dr. Kathryn Anne Hecker, PHARM.D.
Pharmacist
3143 W Colorado Ave, Colorado Springs, CO 80904
719-632-7112
Kelly Ann Chupka, RPH
Pharmacist
7390 Rangewood Dr, Colorado Springs, CO 80918
719-219-1471 719-219-1474
Dr. Kenneth Mark Sudol, PHARMACIST
Pharmacist
1650 Cochrane Cir Unit Meddac, Colorado Springs, CO 80913
719-524-4400
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.